Abstract
In a community-based study of Alzheimer's disease in African Americans age 65 and over, subjects were classified into three levels of performance based on their scores as measured by the Community Screening Instrument for Dementia (CSI"D"), consisting of cognitive and functioning components. In a subset of 268 subjects with apolipoprotein E (APOE) genotype data, we found that the ε4 allele of APOE was associated with intermediate/poor performance (single copy ε4 odds ratio 1.51, 95% CI 1.18 to 1.92; double copy ε4 odds ratio 3.42, 95% CI 2.18 to 5.43). From these data, we believe it would be possible to conduct population screening for the effects of possession of the APOE-ε4 allele using information derived from the CSI"D".
Original language | English (US) |
---|---|
Pages (from-to) | 266-271 |
Number of pages | 6 |
Journal | Ethnicity and Disease |
Volume | 6 |
Issue number | 3-4 |
State | Published - Sep 1996 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Epidemiology
Keywords
- APOE
- African Americans and Community Survey
- Apolipoprotein E
- Cognitive Function
- Dementia